About
Transfection Reagents
Areas of Focus
Categories
Non-Pharmaceutical
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
820
By Phase
PHASE1: 2PHASE2: 4
By Status
RECRUITING: 2COMPLETED: 2NOT_YET_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07123415Lead Sponsor
A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
PHASE1Not yet recruiting
110 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2028
NCT06962098Lead Sponsor
Efficacy and Safety Study of Isuzinaxib in Subjects With DKD
PHASE2Recruiting
186 participants
Started: May 26, 2025 · Completed: Jun 30, 2028
NCT05758896Lead Sponsor
Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI
PHASE2Recruiting
280 participants
Started: Dec 27, 2023 · Completed: Dec 31, 2024
NCT04880109Lead Sponsor
A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.
PHASE2Terminated
16 participants
Started: Oct 20, 2021 · Completed: Apr 28, 2022
NCT04534439Lead Sponsor
Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy
PHASE2Completed
140 participants
Started: Aug 24, 2020 · Completed: Aug 23, 2021
Locations (1)
Headquarters
Yongin, Korea
Map
Loading map...